Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Antimicrobial Peptide Human β-Defensin-3 Accelerates Wound Healing by Promoting Angiogenesis, Cell Migration, and Proliferation Through the FGFR/JAK2/STAT3 Signaling Pathway. | Front Immunol | 2021 | 34594328 | PubTator, text mining | PubMed |
| Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. | Front Nutr | 2021 | 34589512 | PubTator, text mining | PubMed |
| Expression of Antimicrobial Peptides and Cytokines in Human Omentum Following Abdominal Surgery. | Cureus | 2021 | 34589365 | PubTator, text mining | PubMed |
| The effect of ellagic acid on the repair process of periodontal defects related to experimental periodontitis in rats. | J Appl Oral Sci | 2021 | 34586188 | PubTator, text mining | PubMed |
| Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent. | J Cardiothorac Surg | 2021 | 34583720 | PubTator, text mining | PubMed |
| Prognostic value of tumour budding in stomach cancers. | Int J Clin Pract | 2021 | 34580963 | PubTator, text mining | PubMed |
| The Cooperation of Bifidobacterium longum and Active Vitamin D3 on Innate Immunity in Salmonella Colitis Mice via Vitamin D Receptor. | Microorganisms | 2021 | 34576700 | PubTator, text mining | PubMed |
| Bitter Taste Receptor T2R14 Modulates Gram-Positive Bacterial Internalization and Survival in Gingival Epithelial Cells. | Int J Mol Sci | 2021 | 34576085 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Umbilical Cord Blood-Derived Small Extracellular Vesicles and Their Therapeutic Potential for Inflammatory Skin Disorders. | Int J Mol Sci | 2021 | 34575956 | PubTator, text mining | PubMed |
| Chitin Nanofibril Application in Tympanic Membrane Scaffolds to Modulate Inflammatory and Immune Response. | Pharmaceutics | 2021 | 34575515 | PubTator, text mining | PubMed |
| Insights into the Pathogenesis of HS and Therapeutical Approaches. | Biomedicines | 2021 | 34572354 | PubTator, text mining | PubMed |
| Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins. | Eur J Med Chem | 2021 | 34547507 | PubTator, text mining | PubMed |
| Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19. | Microb Pathog | 2021 | 34547411 | PubTator, text mining | PubMed |
| The Functions of BET Proteins in Gene Transcription of Biology and Diseases. | Front Mol Biosci | 2021 | 34540900 | PubTator, text mining | PubMed |
| Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic? | Arch Immunol Ther Exp (Warsz) | 2021 | 34529143 | PubTator, text mining | PubMed |
| Vitamin D Receptor Gene Polymorphisms and Risk of Atopic Dermatitis in Chinese Han Population. | Int J Gen Med | 2021 | 34526805 | PubTator, text mining | PubMed |
| Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis. | Sci Rep | 2021 | 34526600 | PubTator, text mining | PubMed |
| Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations. | Sci Rep | 2021 | 34521933 | PubTator, text mining | PubMed |
| Associations of early childhood caries with salivary beta defensin-3 and childhood anemia: a case-control study. | BMC Oral Health | 2021 | 34521396 | PubTator, text mining | PubMed |
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE). | BMJ Open | 2021 | 34518264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=55